Longhorn Vaccines And Diagnostics, LLC

Bethesda, MD

UEI
LPX8MDPG73Z4
CAGE
6RN02
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Veteran Owned Business
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
7272 Wisconsin Ave Fl 9, Bethesda, MD 20814, USA
Website
lhnvd.com
Founded
2007
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $163,130
FY2026 $0
FY2025 $0
FY2024 $525,875

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Agriculture $163,130

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Longhorn Vaccines And Diagnostics, LLC is a veteran-owned limited liability company registered in SAM.gov since May 15, 2012, with its primary business location in Bethesda, Maryland. The company specializes in producing molecular transport media (MTM) and related diagnostic testing supplies, focusing on scientific and medical testing solutions. As a for-profit organization, Longhorn Vaccines And Diagnostics has established itself as a key supplier of specialized medical and diagnostic products to various federal agencies, with a particular emphasis on providing innovative solutions for sample collection and pathogen testing.

The company has been awarded multiple federal contracts primarily from the Department of Agriculture, specifically the Animal and Plant Health Inspection Service Veterinary Services, for supplying PrimeStore Molecular Transport Medium (MTM) tubes. These contracts have ranged in value from $18,700 to $490,525 and have supported various initiatives, including responses to highly pathogenic avian influenza (HPAI) bovine outbreaks and general veterinary diagnostic needs. The contracts consistently involve the delivery of specialized MTM tubes designed to safely inactivate pathogenic samples while preserving DNA and RNA for testing. None of these contracts were set-aside, and they were awarded as firm-fixed-price purchase orders or definitive contracts, demonstrating Longhorn's ability to provide critical scientific testing supplies across different federal agencies.

Longhorn Vaccines And Diagnostics holds a significant indefinite delivery contract (IDV) with the Federal Emergency Management Agency (FEMA) valued at $200 million, specifically focused on providing testing supplies in support of the COVID-19 response. This multiple-award IDV, titled "Swabs and Media in Support of COVID-19 Response," allows the company to deliver media and saline supplies to aid FEMA's Incident Support Section. Under this contract vehicle, the company has already executed a $25 million delivery order to provide critical sample collection and transport materials. The IDV, awarded on May 4, 2020, with an ultimate completion date of October 1, 2020, underscores Longhorn's strategic importance in supporting national public health emergency responses through the provision of essential diagnostic testing supplies.

SBA capabilities narrative

About Us

Longhorn reflects the visionary spirit of its leadership, Gerald Fischer, MD and Luke Daum, PhD. With an emphasis on innovation, the company has developed unique, groundbreaking products for the molecular testing market that meet critical unmet needs in both the Developed and Developing World.

Quick answers

Is Longhorn Vaccines And Diagnostics, LLC registered in SAM.gov?

Yes. Longhorn Vaccines And Diagnostics, LLC's SAM.gov registration is active through October 9, 2027.

Which contract vehicles does Longhorn Vaccines And Diagnostics, LLC hold?

Longhorn Vaccines And Diagnostics, LLC holds a place on 1 federal contract vehicle: Swabs and Media in Support of COVID-19 Response.

How much has Longhorn Vaccines And Diagnostics, LLC received in federal contracts?

Federal contracts obligated $689,005 to Longhorn Vaccines And Diagnostics, LLC in fiscal years 2023 through 2027.

What is Longhorn Vaccines And Diagnostics, LLC's most recent federal award?

Longhorn Vaccines And Diagnostics, LLC's most recent federal contract award is 1.5ML primestore molecular transport medium (MTM) 5 ML tube (12639527P0003), from Marketing and Regulatory Programs Business Services (APHIS), on October 14, 2026.

On GovTribe

See Longhorn Vaccines And Diagnostics, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors